GGrantIndex
← Leaderboards

William A Altemeier

University Of Washington

$7,061,227
Attributed
$9,580,886
Total exposure
9
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,580,886 · 9

By mechanism

R01$7,816,198 · 4
R21$970,688 · 2
K08$629,035 · 1
S10$118,665 · 1
F32$46,300 · 1

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Response

Research focus

ResponseImmune ResponseSignal TransductionLungExposure ToInflammationCellsLung InjuryPathway InteractionsGenesChemokineIn VivoInflammatoryToll-Like ReceptorsImmunoregulationEpithelial CellsAlveolarPathogenesisInflammatory ResponseLeukocytesGenerationsPathogenDesignAcute

Grant awards (27)

Targeting Angiopoietin-like 4 (ANGPTL4) in Severe Community Acquired Pneumonia$827,909
R01 · FY2025 · HL
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2022 · AI
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2021 · AI
Therapeutic potential of a secreted phospholipase A2 Group X inhibitor in asthma$220,625
R21 · FY2021 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$616,343
R01 · FY2020 · AI
Therapeutic potential of a secreted phospholipase A2 Group X inhibitor in asthma$264,750
R21 · FY2020 · AI · contact PI
Role of cannabinoid receptor 1 in lung injury and resolution$220,625
R21 · FY2020 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$615,325
R01 · FY2019 · AI
Role of cannabinoid receptor 1 in lung injury and resolution$264,688
R21 · FY2019 · AI · contact PI
Impact of versican deficiency on the innate immune response to influenza virus$614,597
R01 · FY2018 · AI
PDGFR-beta+ stromal cells as critical regulators of immune response to tissue injury$426,558
R01 · FY2018 · HL · contact PI
PDGFR-beta+ stromal cells as critical regulators of immune response to tissue injury$426,558
R01 · FY2017 · HL · contact PI
PDGFR-beta+ stromal cells as critical regulators of immune response to tissue injury$426,558
R01 · FY2016 · HL · contact PI
PDGFR-beta+ stromal cells as critical regulators of immune response to tissue injury$426,558
R01 · FY2015 · HL · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$386,100
R01 · FY2012 · HL · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$390,000
R01 · FY2011 · HL · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$390,000
R01 · FY2010 · HL · contact PI
Aerosol Management Platform with Exposure Chamber$118,665
S10 · FY2010 · RR · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$390,000
R01 · FY2009 · HL · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$257,006
R01 · FY2009 · HL · contact PI
Mechanisms of innate immune response modulation by mechanical ventilation$390,000
R01 · FY2008 · HL · contact PI
Immunomodulatory Effects of Mechanical Ventilation$126,063
K08 · FY2007 · HL · contact PI
Immunomodulatory Effects of Mechanical Ventilation$126,063
K08 · FY2006 · HL · contact PI
Immunomodulatory Effects of Mechanical Ventilation$126,063
K08 · FY2005 · HL
Immunomodulatory Effects of Mechanical Ventilation$125,343
K08 · FY2004 · HL
Immunomodulatory Effects of Mechanical Ventilation$125,503
K08 · FY2003 · HL
DETERMINANTS OF REGIONAL VENTILATION HETEROGENEITY$46,300
F32 · FY2000 · HL